Skip to main content

Table 1 Characteristics of patients with UC included in the study

From: A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Age at diagnosis, mean (range)

69.6 years (36–93)

Gender, male

94 cases (80.3 %)

pT stage at initial TUR

 pTa

92 cases (78.6 %)

 pT1

15 cases (12.8 %)

 pTis

10 cases (8.6 %)

Cellular grade at initial TUR

 Low

57 cases (48.7 %)

 High

60 cases (51.3 %)

Intravesical BCG therapy

11 cases

Intravesical chemotherapy (epirubicin)

21 cases

Total cystectomy

16 cases

Bladder cancer-specific mortality

6 cases

All-cause mortality

21 cases

  1. BCG, Bacille Calmette–Guérin